Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis - PubMed (original) (raw)
Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis
Vicki Levidiotis et al. J Am Soc Nephrol. 2004 Jan.
Abstract
The beta-D-endoglycosidase heparanase has been proposed to be important in the pathogenesis of proteinuria by selectively degrading the negatively charged side chains of heparan sulfate proteoglycans within the glomerular basement membrane. A loss of negatively charged heparan sulfate proteoglycans may result in alteration of the permselective properties of the glomerular basement membrane, loss of glomerular epithelial and endothelial cell anchor points, and liberation of growth factors. In this study, therefore, the role of heparanase in passive Heymann nephritis (PHN) was examined. Normal glomeruli showed low-level heparanase expression as determined by immunohistochemistry and Western blot analysis. Days 5, 14, and 28 of PHN were associated with an increase in endothelial and glomerular epithelial cell heparanase. Reverse transcription-PCR confirmed a significant increase in mRNA at day 21 of disease (P < 0.0004). Furthermore, urinary and glomerular heparanase activities were significantly increased at days 5 and 21 of disease, respectively. Western blot analysis of isolated glomeruli separated into membrane- and cytosol-enriched protein fractions showed that the active 58-kD heparanase species was increased but restricted to the cytosol of diseased glomeruli at day 21. The inactive 65-kD precursor, however, was found in membrane and cytosol-diseased fractions, suggesting cell membrane processing. Complement depletion prevented glomerular heparanase expression; in addition, administration of a polyclonal anti-heparanase antibody significantly reduced urinary protein excretion at day 5 of disease to 62 +/- 11 mg/d compared with 203 +/- 43 and 159 +/- 18 mg/d in the normal rabbit serum- and normal saline-treated experimental groups, respectively (P < 0.002). Proteinuria was reduced in the absence of any altered glomerular C5b-9 activity, sheep IgG deposition, or rat anti-sheep antibody titers. These data suggest that heparanase contributes to the pathogenesis of proteinuria in PHN.
Similar articles
- A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis.
Levidiotis V, Freeman C, Punler M, Martinello P, Creese B, Ferro V, van der Vlag J, Berden JH, Parish CR, Power DA. Levidiotis V, et al. J Am Soc Nephrol. 2004 Nov;15(11):2882-92. doi: 10.1097/01.ASN.0000142426.55612.6D. J Am Soc Nephrol. 2004. PMID: 15504941 - Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.
Levidiotis V, Freeman C, Tikellis C, Cooper ME, Power DA. Levidiotis V, et al. Nephrology (Carlton). 2005 Apr;10(2):167-73. doi: 10.1111/j.1440-1797.2005.00388.x. Nephrology (Carlton). 2005. PMID: 15877677 - Sequence of events in the glomerular capillary wall at the onset of proteinuria in passive Heymann nephritis.
Fujigaki Y, Batsford S, Yamashita F, Yonemura K, Hishida A, Kawachi H, Shimizu F, Vogt A. Fujigaki Y, et al. Virchows Arch. 2001 Feb;438(2):136-45. doi: 10.1007/s004280000295. Virchows Arch. 2001. PMID: 11253115 - The role of heparanase in diseases of the glomeruli.
Szymczak M, Kuźniar J, Klinger M. Szymczak M, et al. Arch Immunol Ther Exp (Warsz). 2010 Feb;58(1):45-56. doi: 10.1007/s00005-009-0061-6. Epub 2010 Jan 5. Arch Immunol Ther Exp (Warsz). 2010. PMID: 20049646 Review. - Heparanase in glomerular diseases.
van den Hoven MJ, Rops AL, Vlodavsky I, Levidiotis V, Berden JH, van der Vlag J. van den Hoven MJ, et al. Kidney Int. 2007 Sep;72(5):543-8. doi: 10.1038/sj.ki.5002337. Epub 2007 May 23. Kidney Int. 2007. PMID: 17519955 Review.
Cited by
- Nephroprotective effect of heparanase in experimental nephrotic syndrome.
Assady S, Alter J, Axelman E, Zohar Y, Sabo E, Litvak M, Kaplan M, Ilan N, Vlodavsky I, Abassi Z. Assady S, et al. PLoS One. 2015 Mar 18;10(3):e0119610. doi: 10.1371/journal.pone.0119610. eCollection 2015. PLoS One. 2015. PMID: 25786136 Free PMC article. - Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy.
Borza DB. Borza DB. Front Immunol. 2016 Apr 25;7:157. doi: 10.3389/fimmu.2016.00157. eCollection 2016. Front Immunol. 2016. PMID: 27199983 Free PMC article. Review. - Experimental membranous nephropathy redux.
Cybulsky AV, Quigg RJ, Salant DJ. Cybulsky AV, et al. Am J Physiol Renal Physiol. 2005 Oct;289(4):F660-71. doi: 10.1152/ajprenal.00437.2004. Am J Physiol Renal Physiol. 2005. PMID: 16159900 Free PMC article. Review. - Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation.
Ostrovsky O, Korostishevsky M, Shafat I, Mayorov M, Ilan N, Vlodavsky I, Nagler A. Ostrovsky O, et al. J Leukoc Biol. 2009 Aug;86(2):445-55. doi: 10.1189/jlb.1208735. Epub 2009 Apr 30. J Leukoc Biol. 2009. PMID: 19406828 Free PMC article. - Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
Wijnhoven TJ, van den Hoven MJ, Ding H, van Kuppevelt TH, van der Vlag J, Berden JH, Prinz RA, Lewis EJ, Schwartz M, Xu X. Wijnhoven TJ, et al. Diabetologia. 2008 Feb;51(2):372-82. doi: 10.1007/s00125-007-0879-6. Epub 2007 Dec 6. Diabetologia. 2008. PMID: 18058084
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources